Susquehanna International Group’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,266
| Closed | -$29.8K | – | 13565 |
|
|
2024
Q1 | $29.8K | Buy |
+3,266
| New | +$20.6K | ﹤0.01% | 11721 |
|
|
2023
Q1 | – | Sell |
-528
| Closed | -$20.9K | – | 13771 |
|
|
2022
Q4 | $20.9K | Buy |
+528
| New | +$31.4K | ﹤0.01% | 11750 |
|
|
2020
Q1 | – | Sell |
-97
| Closed | -$16K | – | 11054 |
|
|
2019
Q4 | $16K | Buy |
+97
| New | +$30.8K | ﹤0.01% | 9512 |
|
|
2018
Q4 | – | Sell |
-24
| Closed | -$33K | – | 10187 |
|
|
2018
Q3 | $33K | Buy |
+24
| New | +$32.6K | ﹤0.01% | 8926 |
|
|
2018
Q1 | – | Sell |
-73
| Closed | -$123K | – | 10381 |
|
|
2017
Q4 | $123K | Buy |
+73
| New | +$197K | ﹤0.01% | 8609 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | -$6K | – | 10307 |
|
|
2016
Q3 | $6K | Buy |
+1
| New | +$5.07K | ﹤0.01% | 8303 |
|
|
2013
Q4 | – | Sell |
-1
| Closed | -$79K | – | 9444 |
|
|
2013
Q3 | $79K | Hold |
1
| – | – | ﹤0.01% | 8150 |
|
|
2013
Q2 | $114K | Buy |
+1
| New | +$96.7K | ﹤0.01% | 7741 |
|
Susquehanna International Group's YTEN Position: Q2 2024 in Review
Susquehanna International Group sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 3,266 shares — an estimated $29.8K sold.
Susquehanna International Group first reported a position in YTEN in Q2 2013 and held it in 8 quarters. The position peaked at $123K in Q4 2017. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.
- Susquehanna International Group reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Susquehanna International Group sold 3,266 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $29.8K.
- Susquehanna International Group first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
- Susquehanna International Group's Yield10 Bioscience, Inc. Common Stock position peaked at $123K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.